• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

0.6200 +0.0034 (+0.55%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 275,300
Open 0.6069
Bid (Size) 0.6141 (100)
Ask (Size) 0.6400 (500)
Prev. Close 0.6166
Today's Range 0.6069 - 0.6690
52wk Range 0.5600 - 25.75
Shares Outstanding 171,350,166
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Jaguar Health Announces a Special One-time Stock Dividend
Today 9:00 EST
Via ACCESS Newswire
Monday's after hours session: top gainers and losers ↗
February 09, 2026
Via Chartmill

Performance

YTD
-37.8%
-37.8%
1 Month
-27.5%
-27.5%
3 Month
-54.1%
-54.1%
6 Month
-66.8%
-66.8%
1 Year
-97.5%
-97.5%

More News

Read More
News headline image
Jaguar Health Highlights Sharp Strategic Focus on Rare Intestinal Failure Diseases Fueled by Non-Dilutive Funds from Closing of License Deal for Mytesi
January 22, 2026
Via ACCESS Newswire
Here are the top movers in Tuesday's session. ↗
January 20, 2026
Via Chartmill
Unusual volume stocks are being observed in Tuesday's session. ↗
January 20, 2026
Via Chartmill
Tuesday's session: top gainers and losers ↗
January 20, 2026
Via Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session. ↗
January 20, 2026
Via Chartmill
Wondering what's happening in today's pre-market session? ↗
January 20, 2026
Via Chartmill
Which stocks are moving after the closing bell on Monday? ↗
January 19, 2026
Via Chartmill
Get insights into the top gainers and losers of Friday's after-hours session. ↗
January 16, 2026
Via Chartmill
Which stocks are experiencing notable movement on Friday? ↗
January 16, 2026
Via Chartmill
Curious about the most active stocks on Friday? ↗
January 16, 2026
Via Chartmill
News headline image
The Surge In Jaguar Health Stock: What's Happening Now? ↗
January 16, 2026
Via Benzinga
Keep an eye on the top gainers and losers in Friday's session. ↗
January 16, 2026
Via Chartmill
Friday's session: gap up and gap down stocks ↗
January 16, 2026
Via Chartmill
Get insights into the top gainers and losers of Friday's pre-market session. ↗
January 16, 2026
Via Chartmill
News headline image
Jaguar Health Presenting January 15 at Lytham Partners Healthcare Investor Summit to Provide Updates on Near-Term Catalysts
January 14, 2026
Via ACCESS Newswire
Unusual volume stocks are being observed in Tuesday's session. ↗
January 13, 2026
Via Chartmill
News headline image
Jaguar Health Enters into U.S. License Agreement with Future Pak for Crofelemer, Providing up to $38 Million
January 12, 2026
Via ACCESS Newswire
News headline image
Article About Groundbreaking Results from Study of Jaguar Health's Crofelemer for Treatment of Intestinal Failure Featured in United Arab Emirates Healthcare Publication
January 06, 2026
Via ACCESS Newswire
News headline image
Jaguar Health Awarded $240,000 FDA Grant in Support of Canalevia-CA1 for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
January 02, 2026
Via ACCESS Newswire
News headline image
Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
December 15, 2025
Via ACCESS Newswire
News headline image
FDA Approves Renewal of Canalevia-CA1, Jaguar Health's Drug for Chemotherapy-Induced Diarrhea (CID) in Dogs
December 10, 2025
Via ACCESS Newswire
News headline image
Jaguar Health Reports Approval of All Proposals at December 2025 Special Meeting of Stockholders
December 08, 2025
Via ACCESS Newswire
News headline image
Jaguar Health Makes Submission to EMA Regarding EU Approval Pathway for Canalevia for General Diarrhea in Dogs Based on Data from Completed Study
December 02, 2025
Via ACCESS Newswire

Frequently Asked Questions

Is Jaguar Health, Inc. - Common Stock publicly traded?
Yes, Jaguar Health, Inc. - Common Stock is publicly traded.
What exchange does Jaguar Health, Inc. - Common Stock trade on?
Jaguar Health, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Jaguar Health, Inc. - Common Stock?
The ticker symbol for Jaguar Health, Inc. - Common Stock is JAGX on the Nasdaq Stock Market
What is the current price of Jaguar Health, Inc. - Common Stock?
The current price of Jaguar Health, Inc. - Common Stock is 0.6200
When was Jaguar Health, Inc. - Common Stock last traded?
The last trade of Jaguar Health, Inc. - Common Stock was at 02/18/26 04:00 PM ET
What is the market capitalization of Jaguar Health, Inc. - Common Stock?
The market capitalization of Jaguar Health, Inc. - Common Stock is 106.24M
How many shares of Jaguar Health, Inc. - Common Stock are outstanding?
Jaguar Health, Inc. - Common Stock has 106M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap